Angion Biomedica Corp
ANGN
Get informed when a big investor buys or sells
+ FollowMarket Cap$30.11M
Close$
Share Statistics
| Market cap | $30.11 Million |
|---|---|
| Enterprise Value | $20.03 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.58 |
| Beta | 0.6 |
| Outstanding Shares | 18,211,745 |
Return
| Return on Equity | 2796.45% |
|---|---|
| Return on Assets | -177.11% |
| Return on Invested Capital | -234.48% |
Valuation & Multiples
| P/E Ratio | -0.42 |
|---|---|
| PEG | -7.74 |
| Price to Sales | - |
| Price to Book Ratio | -1.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | -3.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Angion Biomedica Corp
53 employeesAngion Biomedica Corp. is committed to transforming the treatment paradigm for patients suffering from acute organ injuries and fibrotic diseases for which there are no approved medicines or where existing approved medicines have limitat...